Corvus Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018	2017	2016
Market Capitalization	75	86	40	112	100	160	107	218	299
Market Cap Growth	-	118.11%	-64.73%	12.29%	-37.55%	48.85%	-50.70%	-27.10%	-
Enterprise Value	48	61	-0	46	58	85	-7	128	164
PE Ratio	-3.19	-3.19	-0.96	-2.59	-16.66	-3.43	-2.29	-3.92	-8.22
PB Ratio	1.90	2.23	0.71	1.16	1.39	2.25	0.97	2.57	2.25
P/FCF Ratio	-3.60	-3.60	-1.45	-3.06	-2.87	-4.28	-2.60	-4.69	-9.95
P/OCF Ratio	-3.61	-3.61	-1.46	-3.06	-2.87	-4.29	-2.62	-4.72	-10.73
EV/EBITDA Ratio	-2.25	-2.25	0.00	-1.08	-10.81	-1.85	0.15	-2.33	-4.59
EV/EBIT Ratio	-2.24	-2.24	0.00	-1.07	-9.67	-1.82	0.15	-2.30	-4.51
EV/FCF Ratio	-2.53	-2.53	0.00	-1.26	-1.66	-2.28	0.17	-2.75	-5.46
Debt / Equity Ratio	0.04	0.04	0.05	0.04	0.03	0.04	-	-	-
Debt / EBITDA Ratio	-0.05	-0.05	-0.06	-0.09	-0.43	-0.07	-	-	-
Debt / FCF Ratio	-0.06	-0.06	-0.10	-0.10	-0.07	-0.09	-	-	-
Quick Ratio	3.96	3.96	3.99	7.22	3.64	7.63	16.31	10.04	22.69
Current Ratio	4.07	4.07	4.06	7.36	3.73	7.76	16.45	10.17	22.89
Return on Equity (ROE)	-59.60%	-59.60%	-56.80%	-44.00%	-10.60%	-54.60%	-38.00%	-55.40%	-25.10%
Return on Assets (ROA)	-50.60%	-50.60%	-48.30%	-38.70%	-8.60%	-47.70%	-35.30%	-50.40%	-24.10%
Return on Capital (ROIC)	-58.43%	-58.43%	-55.42%	-38.32%	-58.77%	-65.75%	-44.61%	-66.63%	-27.84%
Earnings Yield	-36.75%	-31.32%	-104.39%	-38.55%	-6.00%	-29.18%	-43.68%	-25.53%	-12.16%
FCF Yield	-32.59%	-27.77%	-68.92%	-32.73%	-34.89%	-23.35%	-38.47%	-21.32%	-10.05%
Buyback Yield / Dilution	-3.16%	-3.16%	-11.23%	-41.98%	-0.44%	-6.69%	-34.27%	-32.85%	-4027.48%
Total Shareholder Return	-3.16%	-3.16%	-11.23%	-41.98%	-0.44%	-6.69%	-34.27%	-32.85%	-4027.48%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).